Drug Type Small molecule drug |
Synonyms- |
Target |
Action agonists |
Mechanism CB1 agonists(Cannabinoid CB1 receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC20H20F3N3O3S |
InChIKeyFRMHAUDOBBNIPW-UHFFFAOYSA-N |
CAS Registry3038743-22-2 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pain | Preclinical | United States | 02 Sep 2022 |